BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts
Investor's Business DailyBioNTech stock tumbled Wednesday after the Covid vaccine maker reported light fourth-quarter sales and profit.
The post BioNTech Hits Three-Year Low As Covid Vaccine Sales Plummet 65%, Missing Forecasts appeared first on Investor's Business Daily.